Childhood asthma and measles vaccine response

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 4, 2006, Pages 469-476

  Juhn, Young J ^a   Kita, Hirohito ^a   Lee, Linda A ^a   Swanson, Rebecca J ^a   Smith, Ryan ^a   Bagniewski, Stephanie M ^a   Weaver, Amy L ^a   Pankratz, V Shane ^a   Jacobson, Robert M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEASLES VACCINE; VACCINE; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; ASTHMA; CHI SQUARE TEST; CHILD; CHILDHOOD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SERODIAGNOSIS; STUDENT T TEST; TH2 CELL; UNITED STATES;

EID: 33750096655     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60937-4     Document Type: Article

References (74)

1. World Health Organization. Measles Fact Sheet. Geneva, Switzerland: World Health Organization; 2005.
2. Centers for Disease Control and Prevention. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1998;47(No. RR-8):1-57.
3. Centers for Disease Control and Prevention. Postexposure prophylaxis, isolation, and quarantine to control an import-associated measles outbreak-Iowa, 2004. MMWR Morb Mortal Wkly Rep. 2004;53:969-971.
4. Centers for Disease Control and Prevention. Measles outbreak in a boarding school-Pennsylvania, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:306-309.
5. Centers for Disease Control and Prevention. Measles-Duval County, Florida, 1991-1992. MMWR Morb Mortal Wkly Rep. 1993;42:81-83.
6. Centers for Disease Control and Prevention. Measles outbreak-Southwestern Utah, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:766-769.
7. Centers for Disease Control and Prevention. Measles outbreak among school-aged children-Junea, Alaska, 1996. MMWR Morb Mortal Wkly. 1996;45:777-780.
8. Centers for Disease Control and Prevention. Measles epidemic attributed to inadequate vaccination coverage-Campania, Italy, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:1044-1057.
9. Centers for Disease Control and Prevention. Measles outbreak-Netherlands, April 1999. MMWR Morb Mortal Wkly Rep. 1999;49:299-303.
10. Snapper WM. Interferon-r and B cell stimulatory factor-1 reciprocally regulate Ig isotope production. Science. 1987;236:44.
11. Grove D, Burston T, Wellby M, Ford M, Forbes I. Humoral and cellular immunity in asthma. J Allergy Clin Immunol. 1975;55:152-163.
12. Grove D, Reid JG, Forbes A. Humoural and cellular immunity in atopic asthma. Br J Dermatol. 1975;92:611-618.
13. Berger W, Pollock J, Kiechel F, Dunning M, Pearlman DS. Immunoglobulin levels in children with chronic severe asthma. Ann Allergy. 1978;41:67-74.
14. Hamilos DL, Young RM, Peter JB, Agopian MS, Ikle DN, Barka N. Hypogammaglobulinemia in asthmatic patients. Ann Allergy. 1992;68:472-481.
15. van Den Broek J, Bachmann M, Kohler G, et al. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol. 2000;164:371-378.
16. Graham MB, Braciale VL, Braciale TJ. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med. 1994;180:1273-1282.
17. Moran TM, Isobe H, Fernandez-Sesma A, Schulman JL. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J Virol. 1996;70:5230-5235.
18. 4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med. 1995;181:1285-1292.
19. Fischer JE, Johnson JE, Kuli-Zade RK, et al. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol. 1997;71:8672-8677.
20. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today. 1994;15:575-581.
21. Clerici M, Shearer GM. A TH1->TH2 switch is a critical step in the etiology of HIV infection [see comment]. Immunol Today. 1993;14:107-111.
22. Barker E, Mackewicz CE, Levy JA. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci U S A. 1995;92:11135-11139.
23. Kincy-Cain T, Clements JD, Bost KL. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun. 1437;64:1437-1440.
24. Talbot T, Hartert TV, Arbogast PG, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352:2082-2090.
25. Jacobson R, Poland G, Vierkant R, et al. The association of class I HLA alleles and antibody levels after a single dose of measles vaccine. Human Immunol. 2003;64:103-109.
26. Poland G, Ovsyanniikova I, Jacobson R, et al. Identification of an association between HLA class II alleles and low antibody after measles immunization. Vaccine. 2002;20:430-438.
27. Ovysannikova IG JK, Naylor S, Muddiman DC, Poland GA. Naturally processed measles virus peptide eluted from class II HLA-DRB 1*03 recognized by T lymphocytes from human blood. Virology. 2003;312:495-506.
28. Ovysannikova IG, Johnson KL, Naylor S, Muddiman DC, Vierkant RA, Poland GA. Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides. J Virol. 2004;78:42-51.
29. Ovsyannikova IG, Poland GA, Easler NJ, Vierkant RA. Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals. Human Immunol. 2004;65:209-217.
30. Lara-Marquez M, Yunis J, Layrisse Z, et al. Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population. Clin Exp Allergy. 1999;29:60-71.
31. Torio A, Sanchez-Guerrero I, Muro M, et al. Analysis of the phenotypic distribution of HLA class I and class II in atopic and non-atopic asthma patients. Eur J Immunogenet. 2000;27:81-85.
32. Stephan V, Schmid V, Frischer T, et al. Mite allergy, clinical atopy, and restriction by HLA class II immune response genes. Pediatr Allergy Immunol. 1996;7:28-34.
33. Aron Y, Desmazes-Dufeu N, Matran R, et al. Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7. Clin Exp Allergy. 1996;26:821-828.
34. Di Somma C, Charron D, Deichmann K, Buono C, Ruffilli A. Atopic asthma and TNF-308 alleles: linkage disequilibrium and association analyses. Hum Immunol. 2003;64:359-365.
35. Jeal H, Draper A, Jones M, et al. HLA associations with occupational sensitization to rat lipocalin allergens: a model for other animal allergies? J Allergy Clin Immunol. 2003;111:795-799.
36. Moffatt MF, Schou C, Faux JA, et al. Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample. Eur J Hum Genet. 2001;9:341-346.
37. Juhn Y, Kita H, Poland G, Amy Weaver, Pankratz S, Jacobson R. HLA genotype and childhood asthma. Eur Respir J. 2005;26:694s.
38. Asher MI, Weiland SK. The International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy. 1998;28;52-66.
39. Shaheen S, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissa. Lancet. 1996;347:1792-1796.
40. Lewis SA, Britton JR. Measles infection, measles vaccination and the effect of birth order in the aetiology of hay fever. Clin Exp Allergy. 1998;28:1493-1500.
41. Wickens KL, Crane J, Kemp TJ, et al. Family size, infections, and asthma prevalence in New Zealand children. Epidemiology. 1999;10:699-705.
42. Bodner C, Godden D, Seaton A. Family size, childhood infection and atopic diseases. Thorax. 1998;53:28-32.
43. Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax. 1998;53:927-932.
44. Kuyucu SSY, Tuner A, Sackesen C, Adahoglu G, Sumbuloglu V, Sekerel BE. Determinants of atopic sensitization in Turkish school children: effects of pre- and post-natal events and maternal atopy. Pediatr Allergy Immunol. 2004;15:62-71.
45. Paunio M, Heinonen O, Virtanen M, Leinikki P, Patja A, Peltola H. Measles history and atopic diseases: a population-based cross-sectional study. JAMA. 2000;283:343-346.
46. Bager PWT, Rostgaard K, Hjalgrim H, Melbye M. Age at childhood infections and risk of atopy. Thorax. 2002;57:379-382.
47. Olesen AB, Ellingsen AR, Olesen H, Juul S, Thestrup-Pedersen K. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ. 1997;314:1003-1008.
48. Olesen AB JS, Thestrup-Pedersen K. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta Derm Venereol. 2003;83:445-450.
49. Kurland L, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54-63.
50. Advisory Committee on Immunization Practices. Recommendation for childhood immunization schedule. MMWR Morb Mortal Wkly Rep. 1995;44:1-9.
51. Hanania NA, Sockrider M, Castro M, et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004;113:717-724.
52. Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112(2):e98-103.
53. Yunginger J, Reed CE, O'Connell EJ, Melton J, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma: incidence rates, 1964-1983. Am Rev Respir Dis. 1992;146:888-894.
54. Yawn B, Yunginger JW, Wollan P, Reed CE, Silverstein M, Harris A. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol. 1999;103:54-59.
55. Silverstein M, Reed CE, O'Connell EJ, Melton L, O'Fallon W, Yunginger JW. Long-term survival of a cohort of community residents with asthma. N Engl J Med. 1994;331:1537-1541.
56. Hunt W, Silverstein M, Reed CE, O'Connell EJ, O'Fallon W, Yunginger JW. Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA. 1993;269:1947-1952.
57. Beard M, Yunginger JW, Reed CE, O'Connell EJ, Silverstein MD. Interobserver variability in medical record review: an epidemiological study of asthma. J Clin Epidemiol. 1992;45:1013-1020.
58. Bauer B, Reed CE, Yunginger JW, Wollan P, Silverstein MD. Incidence and outcomes of asthma in the elderly: a population-based study in Rochester, MN. Chest. 1997;111:303-310.
59. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol. 1997;99:466-474.
60. Juhn YJ, Sauvr JS, Katusic SK, Vargas D, Weaver A, Yunginger J. The influence of neighborhood environment on the incidence of childhood asthma: a multilevel approach. Soc Sci Med. In press.
61. Juhn Y, Weaver A, Katusic S, and Yunginger J. Mode of delivery at birth and development of asthma: a population-based cohort study. J Allergy Clin Immunol. 2005;116:510-516.
62. Lahood N, Emerson SS, Kumar P, Sorensen RU. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Ann Allergy. 1993;70:289-294.
63. McIntosh K, Foy H, Modlin JF, Boyer KM, Hilman BC, Gross PA. Multicenter two-dose trials of bivalent influenza A vaccines in asthmatic children aged six to 18 years. J Infect Dis. 1977;136(suppl):S645-S647.
64. Poland G, Jacobson R, Colbourne A, et al. Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects. Vaccine. 1999;17:1525-1531.
65. Poland G. Immunogenetic mechanisms of antibody response to measles vaccine: the role of the HLA genes. Vaccine. 1999;17:1719-1725.
66. Kovarik J, Martinez X, Pihlgren M, et al. Limitations of in vivo IL-12 supplementation strategies to induce Th1 early life responses to model viral and bacterial vaccine antigens. Virology. 2000;268:122-131.
67. Wu VH, McFarland H, Mayo K, Hanger L, Griffin DE, Dhib-Jalbut S. Measles virus-specific cellular immunity in patients with vaccine failure. J Clin Microbiol. 1993;31:118-122.
68. Ruckdeschel JC, Graziano KD, Mardiney MR Jr. Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell Immunol. 1975;17:11-18.
69. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science. 1997;275:77-79.
70. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol. 1993;67:171-177.
71. Ovsyannikova IG, Jacobson RM, Ryan JE, et al. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics. 2005;56:798-807.
72. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937-947.
73. Warner JA ME, Jones AC, Quint DJ, Colwell BM, Warner JO. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy. 1994;24:423-430.
74. Campbell DE, Kemp AS. Measles and atopy in African children [comment]. Lancet. 1996;348:825.